V-W (Pre-2000)

VETERINARY USE / ANIMALS
VISION / EYES (See Also GLAUCOMA, RETINITIS PIGMENTOSA)
WIN 55,212-2 (Synthetic Cannabinoid, CB1 and CB2 Agonist)
WITHDRAWAL SYNDROME


VETERINARY USE / ANIMALS
THE RELATIVE ACTIVITY OF VARIOUS PURIFIED PRODUCTS OBTAINED FROM AMERICAN GROWN HASHISH (abst-1938) http://jpet.aspetjournals.org/content/62/2/239.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=640&resourcetype=HWCIT
Cardiovascular and respiratory effects of cannabis in cat and rat (full-1973) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1776461/
Tolerance to the hypothermic effects of Δ9-tetrahydrocannabinol as a function of age in the chicken (full–1973) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1776369/pdf/brjpharm00549-0026.pdf
Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of delta9-tetrahydrocannabinol (abst–1975) http://www.ncbi.nlm.nih.gov/pubmed/1222370
Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey (abst–1985) http://www.ncbi.nlm.nih.gov/pubmed/2985774
A species comparison of the toxicity of nabilone, a new synthetic cannabinoid (abst–1987) http://www.ncbi.nlm.nih.gov/pubmed/2888699
Species specificity in the metabolism of nabilone. Relationship between toxicity and metabolic routes (abst-1987) http://www.ncbi.nlm.nih.gov/pubmed/3037806
Pharmacokinetics of cannabidiol in dogs (abst-1988) http://dmd.aspetjournals.org/content/16/3/469.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=800&resourcetype=HWCIT
In vitro metabolism of cannabichromene in seven common laboratory animals (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/1981514
In vitro metabolism of delta-11-tetrahydrocannabinol in the mouse, rat, guinea pig, rabbit, hamster, gerbil and cat (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/2253656
In vitro metabolism of cannabigerol in several mammalian species (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/2224182
Behavioral effects of cannabinoid agents in animals (abst-1999) http://www.ncbi.nlm.nih.gov/pubmed/10803637
Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10392859
top


VISION / EYES
CONJUGATE DEVIATION OF THE EYES AFTER Cannabis indica INTOXICATION (full-1964) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=505931&tool=pmcentrez
Delta 9-tetrahydrocannabinol: elevation of absolute visual thresholds of rabbits (abst–1979) http://www.ncbi.nlm.nih.gov/pubmed/482306
Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications (abst-1981) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=88
Mydriasis induced by tetrahydrocannabinol (THC) in rats (link to PDF-1982) http://www.iovs.org/cgi/reprint/22/3/408?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=marihuana&searchid=1&FIRSTINDEX=640&resourcetype=HWCIT
Ocular Effects of Topical Administration of {Delta}9-Tetrahydrocannabinol in Man (abst-1982) http://archopht.amaassn.org/cgi/reprint/100/2/265?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2960&resourcetype=HWCIT
Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene (abst–1984) http://www.ncbi.nlm.nih.gov/pubmed/6323206
Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol (abst–1984) http://www.ncbi.nlm.nih.gov/pubmed/6098513
Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol (abst–1984) http://www.ncbi.nlm.nih.gov/pubmed/6499952
Persistent visual changes following hashish consumption (full-1993) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC513962/?page=1
HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy (abst-1996) http://www.ncbi.nlm.nih.gov/pubmed/8714863
Patent 5631297 – Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same (full–1997) http://www.freepatentsonline.com/5631297.html
Smoking dope restored my sight (news/anecdotal-1998) http://news.bbc.co.uk/2/hi/health/212301.stm
Localization of Cannabinoid CB1 Receptors in the Human Anterior Eye and Retina (full–1999) http://iovs.arvojournals.org/article.aspx?articleid=2162341&resultClick=1
Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10208314
Links found between marijuana and vision (news–1999) http://archives.cnn.com/1999/HEALTH/12/07/science.marijuana/index.html
Cannabinoids’ Role In Retinal Function Described (news-1999) http://www.sciencedaily.com/releases/1999/12/991208061213.htm


WIN 55,212-2
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells (full-1992) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC525583/
Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide (full-1993) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175863/?tool=pmcentrez&page=1
top
(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters (abst-1994) http://www.ncbi.nlm.nih.gov/pubmed/7698178
Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide (abst–1997) http://www.ncbi.nlm.nih.gov/pubmed/9060042
Cannabinoid Receptor Agonists Protect Cultured Rat Hippocampal Neurons from Excitotoxicity (full-1998) http://molpharm.aspetjournals.org/content/54/3/459.full
Loss of Cannabinoid Receptor Binding and Messenger Rna Levels and Cannabinoid Agonist-stimulated [35s]guanylyl-5’o-(Thio)-triphosphate Binding in the Basal Ganglia of Aged Rats (abst-1998) http://www.ncbi.nlm.nih.gov/pubmed/9578396?dopt=Abstract
Cannabinoid modulation of intestinal propulsion in mice (abst–1998) http://www.frontiersin.org/publications/9570450
Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures (full-1999) http://www.jneurosci.org/cgi/content/full/19/8/2987?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats (abst-1999) http://www.ncbi.nlm.nih.gov/pubmed/10611417


WITHDRAWAL SYNDROME
An Abstinence Syndrome Following Chronic Administration of Delta-9-terahydrocannabinol in Rhesus Monkeys (abst–1980) http://www.ncbi.nlm.nih.gov/pubmed/6255508
Marijuana withdrawal syndrome in a woman (abst–1984) http://www.ncbi.nlm.nih.gov/pubmed/6091465
Merck Manual – Marijuana (Cannabis) (excerpt-1987) http://www.ukcia.org/research/merck.htm
Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A (abst–1995) http://www.ncbi.nlm.nih.gov/pubmed/7498260
Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders (abst–1997)
http://www.sciencedirect.com/science/article/pii/S0376871698000039
top